Navigation Links
Jennerex Announces First Patient Treated in Phase 1/2 Clinical Trial of JX-594 in Combination with Irinotecan in Patients with Metastatic Colorectal Cancer
Date:3/20/2012

SAN FRANCISCO, March 20, 2012 /PRNewswire/ -- Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that the first patient has been treated in a Phase 1/2 clinical trial of JX-594 in patients with metastatic colorectal cancer who have become refractory to chemotherapy and are either refractory to or ineligible for cetuximab. The two-arm, dose-escalation study will evaluate JX-594 as a monotherapy and in combination with irinotecan.

The multicenter study will be conducted in the United States, Canada and Europe and is designed to enroll up to 42 patients. Patients will be enrolled in one of two treatment groups—one treatment group will receive JX-594 as a monotherapy and one treatment group will receive JX-594 in combination with irinotecan. Patients in both groups will receive five weekly intravenous infusions of JX-594 at one of two escalating dose levels followed by up to three optional intratumoral injections of JX-594 into metastases to the liver. The combination group will receive concomitant administrations of irinotecan. Once the maximum tolerated dose is determined for each treatment group, additional patients will be enrolled at that dose level. The endpoints of the trial include safety, dose optimization, and tumor responses as measured by RECIST and Choi criteria. For more information about the trial, please visit www.clinicaltrials.gov.

"JX-594, with its three diverse, anticancer mechanisms of action, has shown very strong clinical data to date against multiple tumor types, and it is currently being evaluated in clinical trials for advanced liver and colorectal cancers," said David H. Kirn, M.D., president and chief medical officer of Jennerex. "In the clinical trial announced today, we are particularly interested in o
'/>"/>

SOURCE Jennerex, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Jennerex Completes $8.3 Million Series B Financing and Appoints Dr. Cal Stiller as Director
2. Jennerex Appoints Samantha Miller as Vice President of Corporate Development
3. Nature Reviews Publishes Article About Jennerexs Multi-Mechanistic Cancer Therapeutic
4. Jennerex Closes $5 Million First Tranche of Series C Financing
5. Jennerex Completes Over-Subscribed Series C Financing for Aggregate Gross Proceeds of Over $5.5 Million
6. Jennerex Adds Industry Veteran Paul Cleveland to Board of Directors
7. Jennerex Reports Positive Phase 1 Results for JX-594 Administered Intravenously
8. Jennerex Completes Fully Subscribed Private Placement for Aggregate Gross Proceeds of $8.6 Million
9. Jennerex and Transgene Enter Into an Exclusive Partnership for the Development and Commercialization of JX-594 for the Treatment of Cancers
10. Jennerex Appoints James M. Burke, M.D. Vice President, Clinical Research
11. Jennerex to Present JX-594 Liver Cancer Clinical Data at American Society of Gene and Cell Therapy Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Cardiff, UK (PRWEB) May 17, 2013 ... by Photonics21 at the association’s recent annual ... others including EC Vice-President Neelie Kroes, who called the ... between sectors, and a stimulant to European innovation.” , ... the structure of the new Photonics PPP at its ...
(Date:5/17/2013)... International, Inc. (NASDAQ: YONG ) ("Yongye" or ... crop nutrient products in the People,s Republic ... 16, 2013, the special committee (the "Special Committee") of ... provided a letter (the "Letter") issued by Abax Global ... to Full Alliance International Limited ("Full Alliance"). The Letter, ...
(Date:5/17/2013)... Canada (PRWEB) May 17, 2013 The ... understanding complex biological systems that can help predict the ... speaker Dr. Sergey Stepaniants, Head of Computational Biology at ... computational biology tools to ensure high-quality genomics when used ... can be applied to complex data sets to identify ...
(Date:5/17/2013)... Tooth decay is an epidemic in American ... the disease. The World Health Organization says that worldwide, ... have cavities. What are the long-term effects of this transmissible ... connection between the oral bacterial imbalance and serious systemic issues ... yet it is also 100% preventable? Answer: there has been ...
Breaking Biology Technology:SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 2SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 3Yongye International Provides Update on Status of Proposed Go Private Offer 2Yongye International Provides Update on Status of Proposed Go Private Offer 3Yongye International Provides Update on Status of Proposed Go Private Offer 4Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 3
... known for its innovation and ability to take risks, ... the dynamics and places like South Korea, China and ... India, for example, is gaining ground in software development, ... we hear so much about. The advantages the United ...
... In this final installment of an interview with Carl ... (WARF), Gulbrandsen shares WARFs investment and portfolio strategy, WARFs ... an insightful discussion of WARFs experience with software and ... WARF is Reaching Out to Businesses About Technology Developed ...
... are saying nothing in record numbers. , ,In 2003, an ... services such as LiveJournal , Movable Type , and ... long as a New Year's resolution. , ,A November study ... suggests that 20 percent of all blogs (short for "Web logs") ...
Cached Biology Technology:Keeping Innovation Vibrant in the U.S. 2WTN Interview: Carl Gulbrandsen
WARFs Investment and Portfolio Strategy 2WTN Interview: Carl Gulbrandsen
WARFs Investment and Portfolio Strategy 3WTN Interview: Carl Gulbrandsen
WARFs Investment and Portfolio Strategy 4Who Gives a Blog? 2
(Date:5/16/2013)... May 16, 2013 The relationship between the ... has not been clear. Schizophrenia is commonly associated ... There are clues that reduced IQ may be ... example, reduced cognitive ability may precede the onset ... present in healthy relatives of people diagnosed with ...
(Date:5/16/2013)... hematopoiesis at sites outside the bone marrow in ... (LMU) in Munich now show that a specific type ... blood cells. , Balanced hematopoiesis is essential for the ... takes place mainly in the liver and the spleen. ... and this tissue normally serves as the sole source ...
(Date:5/16/2013)... May 16, 2013 Reportlinker.com announces ... available in its catalogue: ... 2018 http://www.reportlinker.com/p01181929/Global-Biometric-Systems-Market-Forecast--Opportunities-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Security_Systems ... security practises such as photographs, passwords and ... biometric technologies in last few years. Security ...
Breaking Biology News(10 mins):Genetic risk for schizophrenia is connected to reduced IQ 2Herpes infections: Natural killer cells activate hematopoiesis 2Global Biometric Systems Market Forecast & Opportunities, 2018 2Global Biometric Systems Market Forecast & Opportunities, 2018 3Global Biometric Systems Market Forecast & Opportunities, 2018 4Global Biometric Systems Market Forecast & Opportunities, 2018 5Global Biometric Systems Market Forecast & Opportunities, 2018 6Global Biometric Systems Market Forecast & Opportunities, 2018 7
... rapid translation of biologically-based laboratory discoveries into daily clinical ... back from the clinic to the laboratory, to further ... It is imperative for basic researchers to understand and ... knowledge and skills to integrate and use new technologies. ...
... They tell a story, these bleached bones that gleam ... on landscapes like Yellowstone may provide detailed accounts of ... decades or even century, scientists have found. "The ... insights into our understanding of ecosystem history, especially how ...
... new interventional radiology treatment that blocks blood supply ... results to transurethral resection of the prostate (or ... treatment. However, this minimally invasive treatmentprostatic artery embolizationhas ... as sexual dysfunction, urinary incontinence, blood loss and ...
Cached Biology News:Bones of long-dead animals conjure ghosts at Yellowstone 2Bones of long-dead animals conjure ghosts at Yellowstone 3No scalpel: Minimally invasive breakthrough for men’s enlarged prostates improves symptoms 2No scalpel: Minimally invasive breakthrough for men’s enlarged prostates improves symptoms 3No scalpel: Minimally invasive breakthrough for men’s enlarged prostates improves symptoms 4
... RNA Spike-In Kit contains in vitro synthesized, ... complementary control probes on Agilents microarrays, with ... as a positive microarray control in the ... kit is a required component of the ...
... of Microarrays Using the New FAST(tm) Frame ... plate is designed to hold four, 16-pad ... chambers in a microplate footprint for high ... meet the standards recommended by the Society ...
... in a single and twin head, features T ... the most compact, lightweight package in its performance ... air and gas applications., Available in single ... Delivers 1.5 and 2.0 liters per Watt @ ...
... of cells • Blade design minimizes cell ... growth surface • Designed for use in ... • Sterilized by gamma radiation and certified ... new product number, created to easily match ...
Biology Products: